Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
Details:
After ten days of treatment with Phytorelief along with standard management, 83% of Covid-19 patients, with mild or moderate symptoms, turned negative in a trial conduct in AIIMS Patna.
Lead Product(s): Curcuminoid,Ellagic acid,Gingerol
Therapeutic Area: Infections and Infectious Diseases Brand Name: Phytorelief-CC
Study Phase: UndisclosedProduct Type: Small molecule
Sponsor: AIIMS
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable June 10, 2021
Lead Product(s) : Curcuminoid,Ellagic acid,Gingerol
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : AIIMS
Deal Size : Not Applicable
Deal Type : Not Applicable
AIIMS Patna Confirms efficacy of AlchemLife’s Phytorelief a Natural Anti-Viral for Mild to Moder...
Details : After ten days of treatment with Phytorelief along with standard management, 83% of Covid-19 patients, with mild or moderate symptoms, turned negative in a trial conduct in AIIMS Patna.
Brand Name : Phytorelief-CC
Molecule Type : Small molecule
Upfront Cash : Not Applicable
June 10, 2021
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?